Correlation Between Bristol Myers and Solid Biosciences

Can any of the company-specific risk be diversified away by investing in both Bristol Myers and Solid Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol Myers and Solid Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bristol Myers Squibb and Solid Biosciences LLC, you can compare the effects of market volatilities on Bristol Myers and Solid Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol Myers with a short position of Solid Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol Myers and Solid Biosciences.

Diversification Opportunities for Bristol Myers and Solid Biosciences

0.25

Correlation Coefficient

Bristol Myers  Solid Biosciences

Modest diversification

The 3 months correlation between Bristol and Solid is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and Solid Biosciences LLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Solid Biosciences LLC and Bristol Myers is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with Solid Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Solid Biosciences LLC has no effect on the direction of Bristol Myers i.e., Bristol Myers and Solid Biosciences go up and down completely randomly.

Pair Corralation between Bristol Myers and Solid Biosciences

Considering the 90-day investment horizon Bristol Myers is expected to generate 2.46 times less return on investment than Solid Biosciences. But when comparing it to its historical volatility, Bristol Myers Squibb is 4.65 times less risky than Solid Biosciences. It trades about 0.09 of its potential returns per unit of risk. Solid Biosciences LLC is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  407.00  in Solid Biosciences LLC on December 28, 2024 and sell it today you would earn a total of  25.00  from holding Solid Biosciences LLC or generate 6.14% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Bristol Myers Squibb  vs.  Solid Biosciences LLC

Bristol Myers Squibb

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Bristol Myers Squibb are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal primary indicators, Bristol Myers may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Solid Biosciences LLC

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Solid Biosciences LLC are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unsteady fundamental indicators, Solid Biosciences sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Bristol Myers and Solid Biosciences

The main advantage of trading using opposite Bristol Myers and Solid Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol Myers position performs unexpectedly, Solid Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Solid Biosciences will offset losses from the drop in Solid Biosciences' long position.

The idea behind Bristol Myers Squibb and Solid Biosciences LLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.